SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
about
Autoimmune encephalitis updateAutoimmune neuromuscular disordersEarly lung cancer diagnosis by biosensors.Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomasPeripherin-IgG association with neurologic and endocrine autoimmunityParaneoplastic syndromes associated with lung cancerAntibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer.GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders.Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.Screening for tumours in paraneoplastic syndromes: report of an EFNS task force.A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases.Current approaches to the treatment of paraneoplastic encephalitis.Autoimmune channelopathies of the nervous systemVoltage gated calcium channel antibody-related neurological diseasesParaneoplastic neurologic disorders in small cell lung carcinoma: A prospective studyThe role of Sox genes in lung morphogenesis and cancer.Paraneoplastic syndromes of the CNS.Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations.The association between Lambert-Eaton myasthenic syndrome and small cell lung carcinomaSmall-cell lung carcinoma and acute onset of antiglial nuclear antibody-positive limbic encephalitis.Onconeural antibodies in patients with neurological symptoms: detection and clinical significance.Paraneoplastic encephalomyelopathies: pathology and mechanisms.Neural antigen-specific autoimmune disorders.SOX1 antibodies in Lambert-Eaton myasthenic syndrome and screening for small cell lung carcinoma.Lung cancer - can autoantibodies provide an aid to diagnosis?Pathogenic immune mechanisms at the neuromuscular synapse: the role of specific antibody-binding epitopes in myasthenia gravis.Italian recommendations for Lambert-Eaton myasthenic syndrome (LEMS) management.Microtubule-associated protein 1B: Novel paraneoplastic biomarker.Antineuronal autoantibodies in neurological disorders.Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.Ophthalmoplegia associated with lung adenocarcinoma in a patient with the Lambert-Eaton myasthenic syndrome: A case reportLambert-Eaton syndrome antibodies target multiple subunits of voltage-gated Ca2+ channels.Netrin-1 receptor antibodies in thymoma-associated neuromyotonia with myasthenia gravis.Treatment options in paraneoplastic disorders of the peripheral nervous system.Antibodies against cell adhesion molecules and neural structures in paraneoplastic neuropathies.Screening for Tumours in Paraneoplastic Syndromes
P2860
Q26827114-0CE305CD-B124-4D6C-815E-1234C0B97977Q28261039-27F0C04A-8EAE-4781-A49D-8F5FA94E4F9AQ30449799-CAD64093-A4E4-4FFC-8933-827A13B0AABEQ33714734-6FDAE7CD-D581-43D4-87C3-97AF553063E1Q33988689-C72713CD-6D82-4544-A55E-6373A36F4ED4Q34023610-76365873-6700-48E9-A6B4-86A826C81763Q34639948-1BB9BABF-4648-4A4F-BEDF-50315D5A942CQ34647069-0C54D46D-5363-4C19-93DA-D3A50E132426Q34826137-C17F01D8-25A2-4318-9CE4-2AC06CE7E9D1Q34911466-A4AD539C-8D22-431E-B52B-09FC3875B2B2Q35009135-18B94F7D-1205-4E28-BDF8-AAD17A981C41Q35090428-72E99D92-C775-46F9-8E0E-2D5FF745C14FQ35151881-F73C751D-08DF-4B01-9356-1896CC6C614BQ35179343-ECEF18C1-DF84-4856-9B9D-AE95303ED7F4Q35892750-B9B481F7-ADCA-4097-A520-4252843155CEQ36538306-2E3D0BAB-32C6-49E5-B1BA-8779AD704400Q36631871-EA0DE949-A4A7-424F-BD38-EB17716EE55CQ36982702-C69BCFE4-61C8-4828-9CB4-7DFBCF08D349Q37054967-77796D5C-A58E-42C5-9B7B-F1B752815ED6Q37736184-1B6BD106-D710-4314-99D2-B5D614D4FB5EQ37895321-5934F525-3253-47BA-9645-58E9C9E795F1Q37936924-659A2608-E3B9-4ACE-B4DD-5068E84D8582Q38020960-15C26FD0-4C95-4FF4-BBEC-B7CA9DFC892FQ38070757-CAF9FB20-BBEB-4CD0-8897-7F0C637E5D5AQ38089785-E9C842C9-196C-49D3-B1FF-1642E6ABBD5AQ38161532-94B330E3-DD92-428A-AF69-CDF4584426E1Q38183705-14AA0304-0CBC-423B-B404-93041A2FC4A4Q38376430-2BF4E531-1343-4BA5-81B8-E40A26C28568Q38472546-B7B78154-9193-4979-A2BA-5B1CF97AA92BQ39368677-99402CF3-9639-4C14-B737-D7D1316F96B6Q42220674-432EEB8E-24E7-426D-897D-E6AAC0D1B240Q50455790-8049CDE2-4EBE-4A74-8C71-D4DB7955DC83Q51115638-E03CE720-E69F-4CF7-8B3C-7964AC5A7C15Q51838886-E10FF07E-3B34-4FD3-8FD5-26AC6764EFCCQ55017224-2433A729-FF91-4FF0-8221-56A95E9C8937Q57255969-E0807FAA-DD8D-43BE-9719-FC21E5829B4A
P2860
SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
@ast
SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
@en
SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
@nl
type
label
SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
@ast
SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
@en
SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
@nl
prefLabel
SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
@ast
SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
@en
SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
@nl
P2093
P1433
P1476
SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome
@en
P2093
P304
P356
10.1212/01.WNL.0000281663.81079.24
P407
P577
2007-11-21T00:00:00Z